Endocrine therapy considerations in postmenopausal patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancers

Endocrine therapy considerations in postmenopausal patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancers

Item
http://www.wikidata.org/entity/Q28081872
Optimal management of hormone receptor positive metastatic breast cancer in 2016Targeted therapies for ER+/HER2- metastatic breast cancer.MicroRNA-1229 overexpression promotes cell proliferation and tumorigenicity and activates Wnt/β-catenin signaling in breast cancer.A gene expression signature of retinoblastoma loss-of-function is a predictive biomarker of resistance to palbociclib in breast cancer cell lines and is prognostic in patients with ER positive early breast cancer.Efficacy and safety of endocrine monotherapy as first-line treatment for hormone-sensitive advanced breast cancer: A network meta-analysis.Systematic review and network meta-analysis comparing palbociclib with chemotherapy agents for the treatment of postmenopausal women with HR-positive and HER2-negative advanced/metastatic breast cancerThe BMC Medicine breast cancer collection: an illustration of contemporary research and clinical care.Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice.Is There Still a Role for First-Line Single Agent Endocrine Therapy in HR+ and HER2- Advanced Breast Cancer?MiR-503 inhibited cell proliferation of human breast cancer cells by suppressing CCND1 expression.
P2860

Endocrine therapy considerations in postmenopausal patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancers

Item
http://www.wikidata.org/entity/Q28081872
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Endocrine therapy consideratio ...... gative advanced breast cancers
@ast
Endocrine therapy consideratio ...... gative advanced breast cancers
@en
Endocrine therapy consideratio ...... gative advanced breast cancers
@nl
type
label
Endocrine therapy consideratio ...... gative advanced breast cancers
@ast
Endocrine therapy consideratio ...... gative advanced breast cancers
@en
Endocrine therapy consideratio ...... gative advanced breast cancers
@nl
prefLabel
Endocrine therapy consideratio ...... gative advanced breast cancers
@ast
Endocrine therapy consideratio ...... gative advanced breast cancers
@en
Endocrine therapy consideratio ...... gative advanced breast cancers
@nl
P1433
P1476
P2093
P275
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P5008
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Endocrine therapy consideratio ...... gative advanced breast cancers
@en
P2093
P275
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P5008
P577
P5875
P6179
P698
P921
P932